01 1Cipla Limited.
01 1Pharmapia Co., Ltd.
01 1Ambrisentan
01 1India
Registrant Name : Pharmapia Co., Ltd.
Registration Date : 2025-02-18
Registration Number : Su258-30-ND
Manufacturer Name : Cipla Limited.
Manufacturer Address : Plot Nos. A-2, A-33 & A-37/2/2,MIDC, Patalganga, Raigad 410220 Maharashtra State, Ind...
95
PharmaCompass offers a list of Ambrisentan API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Ambrisentan manufacturer or Ambrisentan supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Ambrisentan manufacturer or Ambrisentan supplier.
A BSF 208075 manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of BSF 208075, including repackagers and relabelers. The FDA regulates BSF 208075 manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. BSF 208075 API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of BSF 208075 manufacturers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PhamaCompass.
A BSF 208075 supplier is an individual or a company that provides BSF 208075 active pharmaceutical ingredient (API) or BSF 208075 finished formulations upon request. The BSF 208075 suppliers may include BSF 208075 API manufacturers, exporters, distributors and traders.
click here to find a list of BSF 208075 suppliers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a BSF 208075 Drug Master File in Korea (BSF 208075 KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of BSF 208075. The MFDS reviews the BSF 208075 KDMF as part of the drug registration process and uses the information provided in the BSF 208075 KDMF to evaluate the safety and efficacy of the drug.
After submitting a BSF 208075 KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their BSF 208075 API can apply through the Korea Drug Master File (KDMF).
click here to find a list of BSF 208075 suppliers with KDMF on PharmaCompass.
